Peter Hofland, PhD
  • Male
  • Chandler, AZ
  • United States
Online Now
Share Twitter

Profile Information

Professional (Medical) Affiliation
Medical Research, Pharma, Academia

Peter Hofland

Peter Hofland, PhD's Friends

  • Stacey Broucksou
  • Aileen Eiszele
  • Fabienne Douven
  • Zachary M Rathner
  • jane Walton
  • Kashif
  • Dr.Amin Delawalla
  • Kyu Lim
  • Frank
  • Danielle Friedman
  • Borsani Luisa
  • Dr mir khan
  • Sarah Krug
  • Randy Burton
  • Gideon van der Watt

Peter Hofland, PhD's Videos

  • Add Videos
  • View All

Gifts Received

Gift

Peter Hofland, PhD has not received any gifts yet

Give a Gift

 

Peter Hofland, PhD's Page

Comment Wall (2 comments)

You need to be a member of Onco'Zine to add comments!

Join Onco'Zine

At 12:04pm on January 28, 2013, Ryan Harris said…

This is a new way to network.

At 5:04pm on March 21, 2011, OncologyTube said…

Hi Peter -

 

Are you going to be at ASCO this year? I would love to meet you and perhaps talk more about some business ideas.

 

Sincerly,
Allen Wilbanks

allen@oncologytube.com

404-427-3349

Peter Hofland, PhD's Photos

Loading…
  • Add Photos
  • View All

Peter Hofland, PhD's Blog

First-line Treatment with Panitumumab + FOLFOX in Patients with Wild-type KRAS Metastatic Colorectal Cancer Approved

Posted on May 23, 2014 at 5:30pm 0 Comments

The U.S. Food and Drug Administration (FDA) has approved panitumumab (Vectibix®, Amgen) for use in combination with FOLFOX, an oxaliplatin-based chemotherapy regimen, as first-line treatment in patients with wild-type KRAS (exon 2) metastatic colorectal cancer (mCRC). 

With an estimated number of 96,830 colon and 40,000…

Continue

Thank you Selma!

Posted on May 21, 2014 at 8:00pm 0 Comments

Just a little more than a week before the start of the 50th Annual Meeting of ASCO, the American Society of Clinical Oncology in Chicago, Il, the news landed on my desk that Selma Schimmel, founder and CEO of Vital Options International and an outspoken activist, patient advocate, respected radio talk show host and author had died, aged 59, from malignant psoas syndrome or MPS, a…

Continue

Revisiting Cardiac Screening Guidelines for Survivors of Childhood Cancer: Less Frequent Screening may be Beneficial

Posted on May 19, 2014 at 3:00pm 0 Comments

One of the first studies to analyze the effectiveness of screening survivors of childhood cancer for early signs of impending Congestive Heart Failure or CHF finds improved health outcomes. Hoever, the study suggests that less frequent screening than currently recommended may yield similar clinical benefit. The researchers, in a study published in the Annals of Internal Medicine, utilized a simulation-based…

Continue

Ultra-sensitive Nano-chip Capable of Detecting Early-stage Cancer

Posted on May 18, 2014 at 1:00pm 0 Comments

The majority of cancers today are detected on the macroscopic level, when the tumor already includes millions of cancer cells and the disease is starting to advance into a more mature phase. But what if we could diagnose cancer before it took hold- while it was still only affecting a few localized cells? It could be compared to putting a fire out while there are just a few sparks.

An international team of researchers, led by…

Continue

The Success of Tobacco Control: Study Shows Global Drop in Lung Cancer Rates in Young Women

Posted on May 16, 2014 at 10:30pm 0 Comments

A study published this week as an early online publication in Cancer Epidemiology, Biomarkers & Prevention shows that according to a recent comprehensive analysis of lung cancer rates for women around the world lung cancer rates are dropping in young women in many regions of the globe. The authors of the article suggest that their data points to the success of tobacco control efforts.

However, the data also shows that rates continue to increase among older women in many…

Continue

Experts Find New Ways to Predict Response to Chemo in Triple-negative Breast Cancer

Posted on May 16, 2014 at 2:00pm 0 Comments

Researchers from University Hospitals (UH) Case Medical Center's Seidman Cancer Center found that the presence of tumor-infiltrating lymphocytes, a type of white blood cell, ahead of treatment, may help predict response to platinum-based chemotherapy in women with triple-negative breast cancer. The data, which comes from the PrECOG 0105 trial, will be presented at the 50th annual meeting of the American Society for Clinical…

Continue

Water Pipe-smoking Significantly Increases Exposure to Cancer Causing Agents

Posted on May 16, 2014 at 2:00pm 0 Comments

A study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research (AACR) showed that young adults who smoked water pipes in hookah bars had elevated levels of nicotine, cotinine, tobacco-related cancer-causing agents, and volatile organic compounds or VOC in their urine, increasing their risk for cancer and other chronic diseases.

Commenting on the study, Gideon…

Continue

Researchers find New MicroRNA that may help in Suppressing Prostate Cancer Progression

Posted on May 16, 2014 at 12:00pm 0 Comments

Prostate cancer is the second most common cancer and the second leading cause of cancer-related death in men in the United States. Based on recent data, it is estimated that, in 2013, nearly 239,000 men will be diagnosed with prostate cancer, and nearly 30,000 men will die of the disease. Furthermore, it is estimated that approximately $11.9 billion is spent each year in the United States on prostate cancer treatment.

This is why findings by…

Continue

Researchers to Present Important New Data for ibrutinib in B-Cell Malignancies

Posted on May 15, 2014 at 7:30pm 0 Comments

During the upcoming annual meeting of the American Society of Clinical Oncology (ASCO), to be held May 30 - June 3, 2014, in Chicago, Il, results from the Phase III Resonate™ trial with Ibrutinib (PCI-32765, Imbruvica®; Pharmacyclics), will be featured in ten abstracts, including both company-sponsored research studies and…

Continue

Poor Prognosis in Early Breast Cancer in Patients with CTC

Posted on May 15, 2014 at 10:00am 0 Comments

Circulating tumor cells or CTCs in bone marrow of early breast cancer patients predict a higher risk of relapse as well as poorer survival. To confirm, bone marrow biopsy, an invasive and painful procedure, is generally used to identify these circulating tumor cells. But according to a new study published May 15, 2014 in the Journal of the National Cancer Institute, it may be possible to identify…

Continue
 
 
 

Register for free to view all the Onco'Zine - The International Oncology Network content:

ADVERTISEMENT

Surgeon General’s Report on Smoking & Health—50th Anniversary: 1964-2014

Onco'Zine is present here

Bookmark / Share

CONNECT WITH US AND

JOIN THE CONVERSATION


© 2014   Created by Peter Hofland, PhD.

Badges  |  Report an Issue  |  Terms of Service

Find us on Google+